Pulmonary Hypertension (PH) Completed Phase 4 Trials for Epoprostenol (DB01240)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01462565Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)Treatment
NCT00004754Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary HypertensionTreatment
NCT00373360Safety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to RemodulinTreatment